» Articles » PMID: 33750029

Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis

Overview
Publisher Wiley
Specialty Rheumatology
Date 2021 Mar 22
PMID 33750029
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Eosinophils are tissue-dwelling immune cells. Accumulating evidence indicates that a type of cell death termed ETosis is an important cell fate involved in the pathophysiology of inflammatory diseases. Although the critical role of eosinophils in eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) is well established, the presence of eosinophil ETosis (EETosis) is poorly understood. We undertook this study to better understand the characteristics of EETosis.

Methods: In vitro studies using blood-derived eosinophils were conducted to characterize EETosis. The occurrence of EETosis in tissues from patients with EGPA was studied by immunostaining and electron microscopy. Serum concentrations of eosinophil-derived proteins in healthy controls, patients with asthma, and EGPA patients with active disease or with disease in remission (n = 15 per group) were examined.

Results: EETosis was reliant on reactive oxygen species and peptidylarginine deiminase type 4-dependent histone citrullination, resulting in the cytolytic release of net-like eosinophil extracellular traps, free galectin-10, and membrane-bound intact granules. The signature of EETosis, including loss of cytoplasmic galectin-10 and deposition of granules, was observed in eosinophils infiltrating various tissues from EGPA patients. Serum eosinophil granule proteins and galectin-10 levels were increased in EGPA and positively correlated with disease activity as assessed by the Birmingham Vasculitis Activity Score (r = 0.8531, P < 0.0001 for galectin-10). When normalized to blood eosinophil counts, this correlation remained for galectin-10 (r = 0.7168, P < 0.0001) but not for granule proteins. Galectin-10 levels in active EGPA positively correlated with serum interleukin-5 levels.

Conclusion: Eosinophils infiltrating diseased tissues in EGPA undergo EETosis. Considering the exclusive expression and large pool of cytoplasmic galectin-10 in eosinophils, elevated serum galectin-10 levels in patients with EGPA might reflect the systemic occurrence of cytolytic EETosis.

Citing Articles

Translational approaches to the study of eosinophils in vasculitis.

Egan A, Khoury P Rheumatology (Oxford). 2025; 64(Supplement_1):i19-i23.

PMID: 40071432 PMC: 11897705. DOI: 10.1093/rheumatology/keaf005.


Inhibition of EETosis with an anti-citrullinated histone antibody: a novel therapeutic approach for eosinophilic inflammatory disorders.

Zwiers E, Montizaan D, Kip A, Waaijenberg K, Fichtinger P, Mathur S Front Immunol. 2025; 16:1533407.

PMID: 40051617 PMC: 11882434. DOI: 10.3389/fimmu.2025.1533407.


Eosinophil ETosis and Charcot-Leyden crystals in Kimura disease.

Inoue Y, Ogata H, Sato Y, Kato D, Mitsunaga K, Saito M J Allergy Clin Immunol Glob. 2025; 4(2):100397.

PMID: 39896211 PMC: 11783097. DOI: 10.1016/j.jacig.2024.100397.


IL-18 biology in severe asthma.

Thawanaphong S, Nair A, Volfson E, Nair P, Mukherjee M Front Med (Lausanne). 2024; 11:1486780.

PMID: 39554494 PMC: 11566457. DOI: 10.3389/fmed.2024.1486780.


Characterization of Tissue Immunity Defense Factors of the Lip in Primary Dentition Children with Bilateral Cleft Lip Palate.

Ozola L, Pilmane M J Pers Med. 2024; 14(9).

PMID: 39338219 PMC: 11433168. DOI: 10.3390/jpm14090965.


References
1.
Li P, Li M, Lindberg M, Kennett M, Xiong N, Wang Y . PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010; 207(9):1853-62. PMC: 2931169. DOI: 10.1084/jem.20100239. View

2.
Furuta S, Iwamoto T, Nakajima H . Update on eosinophilic granulomatosis with polyangiitis. Allergol Int. 2019; 68(4):430-436. DOI: 10.1016/j.alit.2019.06.004. View

3.
Guilpain P, Auclair J, Tamby M, Servettaz A, Mahr A, Weill B . Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome. Ann N Y Acad Sci. 2007; 1107:392-9. DOI: 10.1196/annals.1381.041. View

4.
Saffari H, Hoffman L, Peterson K, Fang J, Leiferman K, Pease 3rd L . Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2014; 133(6):1728-34.e1. DOI: 10.1016/j.jaci.2013.11.024. View

5.
Melo R, Weller P . Contemporary understanding of the secretory granules in human eosinophils. J Leukoc Biol. 2018; 104(1):85-93. PMC: 6013358. DOI: 10.1002/JLB.3MR1217-476R. View